1. Therapeutic antibodies against cancer stem cells: a promising approach

   • Smarakan Sneha
   • Rohit Pravin Nagare
   • Trivadi Sundaram Ganesan

   Review 24 August 2017 Pages: 1383 - 1398

   

2. Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review

   • Marie-Léa Gauci
   • Pauline Laly
   • Jean-François Gautier

   Original Article 20 June 2017 Pages: 1399 - 1410

   

3. Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells

   • Timothy T. Spear
   • Yuan Wang
   • Michael I. Nishimura

   Original Article 20 June 2017 Pages: 1411 - 1424

   

4. The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

   • Fiona C. Thistlethwaite
   • David E. Gilham
   • Robert E. Hawkins

   Original Article Open access 28 June 2017 Pages: 1425 - 1436

   

5. Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer

   • Robert Wesolowski
   • Megan C. Duggan
   • William E. Carson III

   Original Article 07 July 2017 Pages: 1437 - 1447

   

6. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases

   • Erna-Elise Paulsen
   • Thomas K. Kilvaer
   • Tom Donnem

   Original Article Open access 13 July 2017 Pages: 1449 - 1461

   

7. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies

   • Margrethe Raspotnig
   • Mette Haugen
   • Christian A. Vedeler

   Original Article 14 July 2017 Pages: 1463 - 1471

   

8. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy

   • Frida Ewald Sander
   • Malin Nilsson
   • Anna Martner

   Original Article Open access 18 July 2017 Pages: 1473 - 1484

   

9. IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model

   • Shuku-ei Ito
   • Hidekazu Shirota
   • Chikashi Ishioka

   Original Article 21 July 2017 Pages: 1485 - 1496

   

10. “Tumor immunology meets oncology (TIMO) XII”, April 28th–30th 2016, Halle/Saale, Germany

    • Barbara Seliger

    Meeting Report 10 July 2017 Pages: 1497 - 1503

11. CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target

    • Astrid Holzinger
    • Hinrich Abken

    Letter to the Editors 28 July 2017 Pages: 1505 - 1507